Drug allergy to CFTR modulator therapy associated with lumacaftor-specific CD4+ T lymphocytes. (2021)
Attributed to:
Development of a stepwise screening approach to assess the intrinsic immunogenicity of drugs and chemicals
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jaci.2020.05.041
PubMed Identifier: 32526307
Publication URI: http://europepmc.org/abstract/MED/32526307
Type: Journal Article/Review
Volume: 147
Parent Publication: The Journal of allergy and clinical immunology
Issue: 2
ISSN: 0091-6749